Phenotyping Angiotensin-Converting Enzyme in Blood: A Necessary Approach for Precision Medicine
Open Access
- 7 June 2021
- journal article
- research article
- Published by Oxford University Press (OUP) in The Journal of Applied Laboratory Medicine
- Vol. 6 (5) , 1179-1191
Abstract
Angiotensin-converting enzyme (ACE) metabolizes a number of important peptides participating in blood pressure regulation and vascular remodeling. Elevated ACE expression in tissues (which is generally reflected by ACE in blood) is associated with increased risk of cardiovascular diseases. Elevated ACE in blood is also a marker for granulomatous diseases. We applied our novel approach—ACE phenotyping—to characterize serum ACE in 300 unrelated patients and to establish normal values for ACE levels. ACE phenotyping includes (a) determination of ACE activity with 2 substrates (Z-Phe-His-Leu [ZPHL] and Hip-His-Leu [HHL]), (b) calculation of a ratio for hydrolysis of ZPHL and HHL, and (c) quantification of ACE immunoreactive protein levels and ACE conformation with a set of monoclonal antibodies (mAbs) to ACE. Only a combination of ACE activity determination with 2 substrates and quantification of the amount of ACE immunoreactive protein with mAbs 1G12 and 9B9 allows for the unequivocal detection of the presence of ACE inhibitors in the blood. After excluding such subjects, we were able to establish normal values of ACE in healthy populations: 50%–150% from control pooled serum. This ACE phenotyping approach in screening format with special attention to outliers can also identify patients with various mutations in ACE and may help to identify the as yet unknown ACE secretase or other mechanistic details of precise regulation of ACE expression. ACE phenotyping is a promising new approach with potential clinical significance to advance precision medicine screening techniques by establishing different risk groups based on ACE phenotype.Keywords
Funding Information
- University of Illinois at Chicago Center for Clinical and Translational Science (UL1TR002003)
This publication has 40 references indexed in Scilit:
- Conformational Changes of Blood ACE in Chronic UremiaPLOS ONE, 2012
- Spectrum of mutations in the renin-angiotensin system genes in autosomal recessive renal tubular dysgenesisHuman Mutation, 2011
- The ACE Gene and Human PerformanceSports Medicine, 2011
- Aptamer-Based Multiplexed Proteomic Technology for Biomarker DiscoveryPLOS ONE, 2010
- Conformational Fingerprinting of the Angiotensin I-Converting Enzyme (ACE). 1. Application in SarcoidosisJournal of Proteome Research, 2010
- ACE phenotyping as a first step toward personalized medicine for ACE inhibitors. Why does ACE genotyping not predict the therapeutic efficacy of ACE inhibition?Pharmacology & Therapeutics, 2006
- A high-throughput fluorimetric assay for angiotensin I-converting enzymeNature Protocols, 2006
- Genetic associations with human longevity at the APOE and ACE lociNature Genetics, 1994
- An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels.Journal of Clinical Investigation, 1990
- Angiotensin-converting enzyme in cultured endothelial cells. Synthesis, degradation, and transfer to culture medium.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1983